BIO's top-notch education program covers the biotechnology and pharma industry's most relevant and timely topics - providing the know-how you need to advance your business. In each session, top thought leaders offer insights on issues essential to the industry and provide a wealth of information of strategic relevance to your business.
.png?n=1661 "BIO2019-ProgramAnnouncement-email-FDAtownhall")
Biofuels & Renewable Chemicals
Business Development & Finance - sponsored by Pfizer Inc.
.png "DigitalHealth Icon")
Digital Health - sponsored by EY
Emerging Opportunities in Global Markets - sponsored by Amgen
.png "highly prevalent chronic diseases"){kind=icon}
NEW! Highly Prevalent Chronic Diseases
Infectious Diseases & Vaccines - sponsored by GlaxoSmithKline
Next Generation Biotherapeutics - sponsored by Spark Therapeutics
Oncology - sponsored by Bristol-Myers Squibb
Opioids: Changing the Paradigm on Treating Pain and Addiction
Orphan & Rare Diseases- sponsored by CSL Behring, Premier Research, & Retrophin
NEW! Patient Advocacy - sponsored by Merck & Co., Inc.
Personalized Medicine & Diagnostics - sponsored by Genentech
Regulatory Innovation - sponsored by Parexel
.png "TranslationalResearch Icon")
Translational Research - sponsored by Clarivate Analytics
Value, Patient Access, & Reimbursement - sponsored by Amgen & Celgene
Thank you to the 2019 BIO International Convention Program Committee for their devoted efforts in creating a world-class education program. The Committee meets on a continuing basis to determine the most cutting edge topics and speakers, and is led by Program Chairs and supported by numerous individuals in all sectors of biotechnology.
For more insight into the educational planning process, check out this exclusive blog post written by former BIO Program Committee Co-Chair, Rob Wright, Chief Editor of Life Science Leader.
Brain Health
Genome Editing
Intellectual Property